Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec;17(12):965-70.
doi: 10.1038/gim.2015.12. Epub 2015 Mar 12.

Ultra-orphan Diseases: A Quantitative Analysis of the Natural History of Molybdenum Cofactor Deficiency

Affiliations

Ultra-orphan Diseases: A Quantitative Analysis of the Natural History of Molybdenum Cofactor Deficiency

Konstantin Mechler et al. Genet Med. .

Abstract

Purpose: Experimental treatment with substrate replacement was successfully performed in single cases with molybdenum cofactor deficiency type A. The objective of this study was to quantitate the yet undefined natural history in untreated patients to ultimately benefit knowledge in experimental treatments in the future.

Methods: Systematic analysis of published cases with molybdenum cofactor deficiency. The main outcome measures were survival, initial cardinal disease features at onset, and diagnostic delay.

Results: The median survival for the overall population was 36 months. Initial cardinal disease features at onset were seizures (72%) as well as feeding difficulties (26%) and hypotonia (11%). In addition, developmental delay (9%), hemiplegia (2%), lens dislocation (2%), and hyperreflexia (1%) were reported. The median age at onset of the disease was the first day of life; the median age at diagnosis was 4.5 months. The median time to diagnosis (diagnostic delay) was 89 days.

Conclusion: Molybdenum cofactor deficiency has its onset during the neonatal period and infancy. There is considerable diagnostic delay. Although seizures were the most frequent initial cardinal sign, molybdenum cofactor deficiency should be considered as a differential diagnosis in patients presenting with hypotonia, developmental delay, or feeding difficulties. The survival data will inform further natural-history and therapeutic studies.

Similar articles

See all similar articles

Cited by 11 articles

See all "Cited by" articles

References

    1. J Inherit Metab Dis. 2009 Aug;32(4):560-9 - PubMed
    1. Hum Mol Genet. 2004 Jun 15;13(12):1249-55 - PubMed
    1. AJNR Am J Neuroradiol. 1996 Feb;17(2):317-20 - PubMed
    1. J Intern Med. 2013 Oct;274(4):331-41 - PubMed
    1. Lancet. 2009 Dec 12;374(9706):1986-96 - PubMed

MeSH terms

Supplementary concepts

Feedback